Maak Biotech & ResearchContact

Peptide biotechnology · Muscat, Oman

Biotechnology programmes.Directed from Oman.

Maak Biotech & Research leads proprietary research and professional peptide programmes from Muscat. Scientific direction, quality oversight and intellectual property remain with Maak, supported by qualified international synthesis, analytical and logistics capacity.

Explore MK-1 Peptide services
Proprietary programme · MK-1Professional peptide projectsHeadquartered in MuscatPlanned IPM facility

Commercial model

Proprietary asset value combined with contracted programme revenue.

MK-1 and future proprietary programmes create licensing and co-development potential. Peptide services, contracted research and authorised research-material supply provide a parallel commercial route, managed through the same Oman-led partner and quality network.

How Maak operates

Company activities

Three activities.
One accountable organisation.

Maak concentrates capital and talent on programme ownership in Oman, then commissions specialised infrastructure where it adds the greatest technical value.

01

Proprietary R&D

MK-1 leads a focused research portfolio in peptide-based neural repair and proteoglycan biology.

Explore
02

Peptide programmes

Technical scoping, synthesis coordination, analytical planning, documentation and research-material supply for professional clients.

Explore
03

Oman operations

Programme direction, quality oversight, intellectual property and commercial coordination led from Muscat.

Explore

Lead proprietary programme

A peptide programme in the biology that limits neural repair.

MK-1 addresses injury-associated proteoglycan signalling around PTPσ, a recognised regulator of axonal growth and plasticity. The programme translates a strong external scientific foundation into proprietary development work spanning molecular interaction, neurite outgrowth and translational neurobiology.

Programme areaPreclinical neural repair
Explore MK-1

Operating model

Maak retains the decisions that create programme value.

Specialist work is commissioned internationally; programme leadership and ownership remain in Oman.

01

Design

Set the scientific objective, technical brief, work packages and review points.

02

Commission

Select qualified synthesis, analytical, research and logistics providers for each project.

03

Control

Review data, specifications, certificates, deviations, records and material status.

04

Advance

Manage intellectual property, programme decisions, partnerships and commercial development.

Professional services

Peptide projects managed from technical brief to delivery.

Maak coordinates specialist manufacturers, analytical laboratories and logistics providers around a defined client requirement. The result is a structured programme with clear specifications, documented review and a single commercial interface.

  • Custom and research-grade peptide programmes
  • cGMP synthesis coordination through qualified manufacturers
  • Analytical, batch-documentation and supply coordination
View peptide services
Innovation Park Muscat · Planned facility

Building in Muscat

A permanent headquarters with room to scale.

Maak is seeking an approximately 1,000 m² plot at Innovation Park Muscat for an integrated headquarters and phased biotechnology facility. The first building is planned around an approximately 100 m² office, R&D and quality support, secure records and controlled material operations, with space retained for future laboratory expansion.

View the Oman facility plan

Work with Maak

Discuss a peptide programme, scientific collaboration or strategic partnership.

Contact Maak